Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kouta Aoyama"'
Autor:
Kazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Masahiro Takihata, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Akira Kanamori, Hisakazu Degawa, Hareaki Yamamoto, Hideo Machimura, Atsuko Mokubo, Keiichi Chin, Mitsuo Obana, Toshimasa Hishiki, Kouta Aoyama, Shinichi Nakajima, Shinichi Umezawa, Hidetoshi Shimura, Togo Aoyama, Kazuyoshi Sato, Masaaki Miyakawa
Publikováno v:
Clinical and Experimental Hypertension, Vol 41, Iss 7, Pp 637-644 (2019)
Decrease in blood pressure contributes to the reno-protective effects of sodium-glucose cotransporter 2 inhibitors; however, its relationship with home monitoring of blood pressure is unclear. We retrospectively analyzed 101 visiting members of the K
Externí odkaz:
https://doaj.org/article/b1b31d2ac3f746d1be93392f3402d38a
Autor:
Kazuo Kobayashi, Masao Toyoda, Noriko Kaneyama, Nobuo Hatori, Takayuki Furuki, Hiroyuki Sakai, Masahiro Takihata, Tomoya Umezono, Shun Ito, Daisuke Suzuki, Hiroshi Takeda, Akira Kanamori, Hisakazu Degawa, Hareaki Yamamoto, Hideo Machimura, Atsuko Mokubo, Keiichi Chin, Mitsuo Obana, Toshimasa Hishiki, Kouta Aoyama, Shinichi Nakajima, Shinichi Umezawa, Hidetoshi Shimura, Togo Aoyama, Masaaki Miyakawa
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Aim. The renoprotective effect of sodium-glucose cotransporter 2 inhibitors is thought to be due, at least in part, to a decrease in blood pressure. The aim of this study was to determine the renal effects of these inhibitors in low blood pressure pa
Externí odkaz:
https://doaj.org/article/1fa7d3057ac64d3b92a640d8898447ba
Autor:
Kouta Aoyama, Shun Ito, Masaaki Miyakawa, Kouichi Tamura, Nobumichi Saito, Tomoya Umezono, Shinichi Umezawa, Toshimasa Hishiki, Fuyuki Minagawa, Hareaki Yamamoto, Masao Toyoda, Daisuke Suzuki, Kazuo Kobayashi, Keiichi Chin, Masahiro Takihata, Togo Aoyama, Kazuyoshi Sato, Hiroshi Takeda, Hideo Machimura, Yutaka Hatori, Hisakazu Degawa, Takayuki Furuki, Kohsuke Minamisawa, Masahiro Hayashi, Yoshiro Hamada, Hiroyuki Sakai, Yoshiro Suzuki, Tomohiko Kanaoka, Akira Kanamori, Nobuo Hatori
Publikováno v:
Diabetes Technology & Therapeutics. 23:110-119
Aim: Sodium–glucose cotransporter 2 inhibitors (SGLT2is) provide renal protection in patients with type 2 diabetes mellitus (T2DM). The aim of this study was to elucidate the renal effects of long-...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99dd961a2971743589161a8a49c6bdb0
https://doi.org/10.1089/dia.2020.0165
https://doi.org/10.1089/dia.2020.0165
Autor:
Hareaki Yamamoto, Akira Kanamori, Daisuke Suzuki, Masao Toyoda, Nobuo Hatori, Hisakazu Degawa, Kazuyoshi Sato, Takayuki Furuki, Hiroyuki Sakai, Kouta Aoyama, Kouichi Tamura, Keiichi Chin, Masahiro Takihata, Shun Ito, Fuyuki Minagawa, Masahiro Hayashi, Toshimasa Hishiki, Kohsuke Minamisawa, Yoshiro Suzuki, Hiroshi Takeda, Togo Aoyama, Hideo Machimura, Yutaka Hatori, Shinichi Umezawa, Masaaki Miyakawa, Yoshiro Hamada, Tomoya Umezono, Kazuo Kobayashi
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Sodium–glucose cotransporter 2 inhibitors (SGLT2i) improve renal outcome in patients with type 2 diabetes mellitus, but the mechanism is not fully understood. The aim of this retrospective study was to assess the association of ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d90d68fb7086a6035d4081737e5c450
https://doi.org/10.1111/jdi.13318
https://doi.org/10.1111/jdi.13318
Autor:
Keiichi Chin, Masahiro Takihata, Kazuyoshi Sato, Hisakazu Degawa, Shun Ito, Togo Aoyama, Masaaki Miyakawa, Shinichi Nakajima, Atsuko Mokubo, Akira Kanamori, Daisuke Suzuki, Hidetoshi Shimura, Hiroshi Takeda, Nobuo Hatori, Moritsugu Kimura, Hiroyuki Sakai, Hareaki Yamamoto, Shinichi Umezawa, Toshimasa Hishiki, Mitsuo Obana, Takayuki Furuki, Tomoya Umezono, Kazuo Kobayashi, Hideo Machimura, Masao Toyoda, Kouta Aoyama
Publikováno v:
Clinical and Experimental Hypertension. 41:637-644
Decrease in blood pressure contributes to the reno-protective effects of sodium-glucose cotransporter 2 inhibitors; however, its relationship with home monitoring of blood pressure is unclear. We retrospectively analyzed 101 visiting members of the K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::908c8d8d3e1f28d5d157ed123bc8b9e7
https://doi.org/10.1080/10641963.2018.1529778
https://doi.org/10.1080/10641963.2018.1529778
Autor:
Toshimasa Hishiki, Akira Kanamori, Atsuko Mokubo, Kouta Aoyama, Hidetoshi Shimura, Nobuo Hatori, Shinichi Nakajima, Daisuke Suzuki, Takayuki Furuki, Tomoya Umezono, Moritsugu Kimura, Masao Toyoda, Kazuo Kobayashi, Keiichi Chin, Masahiro Takihata, Hisakazu Degawa, Hiroshi Takeda, Mitsuo Obana, Shun Ito, Kazuyoshi Sato, Masaaki Miyakawa, Togo Aoyama, Hareaki Yamamoto, Hiroyuki Sakai, Shinichi Umezawa, Hideo Machimura
Publikováno v:
Diabetes and Vascular Disease Research. 16:103-107
The aim of this study was to assess the renal effects of the glucose-lowering SGLT2 inhibitors in Japanese type 2 diabetes mellitus patients with chronic kidney disease.The Kanagawa Physicians Association maintains a registry of patients who visit th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::020df65e90ee74c4906f0e92ecab605b
https://doi.org/10.1177/1479164118802759
https://doi.org/10.1177/1479164118802759
Autor:
Atsuko Mokubo, Hidetoshi Shimura, Noriko Kaneyama, Hideo Machimura, Shinichi Umezawa, Togo Aoyama, Keiichi Chin, Mitsuo Obana, Akira Kanamori, Masahiro Takihata, Toshimasa Hishiki, Nobuo Hatori, Hiroyuki Sakai, Shinichi Nakajima, Daisuke Suzuki, Tomoya Umezono, Kouta Aoyama, Kazuo Kobayashi, Hisakazu Degawa, Masao Toyoda, Shun Ito, Masaaki Miyakawa, Hareaki Yamamoto, Takayuki Furuki, Hiroshi Takeda
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Journal of Diabetes Research
Journal of Diabetes Research
Aim. The renoprotective effect of sodium-glucose cotransporter 2 inhibitors is thought to be due, at least in part, to a decrease in blood pressure. The aim of this study was to determine the renal effects of these inhibitors in low blood pressure pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::791215a5d8a1ffd741ea959817577dfc
https://doaj.org/article/1fa7d3057ac64d3b92a640d8898447ba
https://doaj.org/article/1fa7d3057ac64d3b92a640d8898447ba